We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: boohoo Launches UK Supply Chain Review

Wed, 08th Jul 2020 07:43

(Alliance News) - Stock in London are set to open in negative territory on Wednesday, following a lower close in the US overnight, with traders focusing on UK Chancellor Rishi Sunak speech scheduled later in the day.

On the corporate front, transport company FirstGroup reported a widened loss in its most recently ended financial year amid additional charges, while clothing retailer boohoo launched an independent review of its UK supply chain.

IG says futures indicate the FTSE 100 index of large-caps to open 44.60 points lower at 6,145.30 on Wednesday. The blue-chip index closed down 96.04 points, or 1.5%, at 6,189.90 on Tuesday.

"Stock markets in Europe lost ground yesterday as traders were quick to book their profits from the impressive gains that were racked up on Monday," said CMC Markets UK analyst David Madden. "Yesterday's move was more about a correction rather than a sharp change in outlook."

The economic events calendar on Wednesday has summer economic update from UK Chancellor Rishi Sunak at 1230 BST and US consumer credit at 2000 BST.

"Rishi Sunak, the chancellor of the Exchequer, will be in focus today as he is tipped to unveil various schemes that are aimed at aiding the economy. Some of the programmes have already been announced," added Madden.

Homeowners will receive GBP2 billion in financial incentives to insulate their homes as part of an economic recovery scheme set to be announced by the Chancellor.

The funding is part of an expected GBP3 billion green package Rishi Sunak will unveil on Wednesday to create jobs, upgrade buildings and protect the environment as part of efforts to rebuild the economy after Covid-19.

The scheme will also include a GBP1 billion programme to transform schools, hospitals and other public buildings so they are greener and more energy efficient.

In early company news, drugmaker AstraZeneca said Lynparza has been approved in the EU for patients with germline BRCA-mutated metastatic pancreatic cancer.

The approval was based on results from the phase III Polo trial.

"Today's approval opens the door to a new era of biomarker-led care for patients with metastatic pancreatic cancer in the EU, which has the highest incidence of any region globally," said Hedy Kindler, co-principal investigator of the POLO trial.

Real estate investment trust SEGRO updated the market on rental collections from its UK portfolio associated with the UK quarterly payment date of June 24, saying that 93% of the GBP37 million of rent due was received.

The company noted that GBP9 million of rent ordinarily due on the UK quarterly payment date has been re-profiled, mostly to be paid in the second half of 2020.

Turning to FTSE 250-listed, Aberdeen, Scotland-based transport company FirstGroup reported widened a pretax loss of GBP299.6 million for the year to the end of March compared with GBP97.9 million loss a year ago.

FirstGroup explained that the loss reflects charges relating to the North American self-insurance provision, Greyhound impairment charges, restructuring and reorganisation costs and coronavirus-related charges.

Trading trends prior to the pandemic were broadly similar throughout the year, the company noted, with industry cost pressures offset by revenue growth in First Student, First Transit and First Bus and management actions.

Annual revenue, meanwhile, grew to GBP7.75 billion from GBP7.13 billion year-on-year.

FirstGroup is not proposing to pay a dividend for financial 2020, but said it will continue to review the appropriate timing for restarting dividend payments.

Property investment company CLS Holdings said vacancy rates have increased from the end of December 2019 levels due to refurbishments, acquired vacancy in the UK and some recent lease expiries across the portfolio.

Since April 8, there have been 25 deals securing GBP3.2 million of annual rent, CLS said.

The company said its balance sheet remains well-capitalised and robust. As at the end of June, CLS had cash of over GBP190 million, with a further GBP50 million in undrawn facilities.

Lancashire, England-based Victrex said it had a solid start but weaker end to its third quarter as Covid-19 headwinds hurt performance.

The polymer solutions provider reported a 12% drop in sales volume for the three months to the end of June to 805 tonnes, with revenue down 18% to GBP58.8 million, reflecting mix as a key driver.

On a year-to-date basis, Victrex sales volume of 2,797 tonnes was broadly in line with the prior year's 2,811 tonnes. Year-to-date revenue stands at GBP210.3 million, down 3% compared to GBP217.8 million a year prior.

Looking ahead, Victrex said with lower production levels and a weak product mix will hurt margins in the second half and in financial 2021.

Elsewhere, boohoo said it is launching an immediate independent review of its UK supply chain, led by Alison Levitt QC. The fashion retailer said it is also accelerating its independent third party supply chain review with ethical audit and compliance specialists Verisio and Bureau Veritas.

In addition, boohoo said it will be making an initial commitment to invest an incremental GBP10 million to eradicate supply chain malpractice.

The move comes after Next and ASOS have dropped boohoo clothing from their websites after claims that the fast-fashion retailer sold clothes made in factories where staff were paid less than the minimum wage and worked in poor conditions.

boohoo has had more than GBP1 billion wiped from its share value in the past two days after an article in the Sunday Times newspaper alleged that workers in a Leicester factory making clothes destined for boohoo were being paid as little as GBP3.50 an hour.

In New York on Tuesday, the Dow Jones Industrial Average ended down 1.5%, the S&P 500 down 1.1%, and the Nasdaq Composite down 0.9%.

US President Donald Trump has formally started the withdrawal of the US from the World Health Organization, making good on threats over the UN body's response to the coronavirus, officials said Tuesday.

The US is the largest financial contributor to the WHO – which leads the fight on global maladies from polio to measles to mental health – but it has increasingly been in Trump's crosshairs as the coronavirus takes a heavy toll.

After threatening to suspend the USD400 million in annual US contributions and then announcing a withdrawal, Trump has formally informed UN Secretary-General Antonio Guterres that he has started the US pullout, a State Department spokesperson said.

The withdrawal is effective in one year – July 6, 2021 – and Joe Biden, Trump's presumptive Democratic opponent, is virtually certain to stop it and stay in the WHO if he defeats Trump in the November election.

The US, the country hardest hit by the coronavirus, on Tuesday posted 60,209 new cases, a record for a 24-hour period, according to a tally from Johns Hopkins University.

In Asia on Wednesday, Nikkei 225 index in Tokyo closed down 0.8%. In China, the Shanghai Composite is up 1.8%, while the Hang Seng index in Hong Kong is up 0.3%.

China opened a new office on Wednesday for its intelligence agents to operate openly in Hong Kong for the first time under a tough new security law, in a public display of its tightening control over the finance hub.

The new base is located in a rapidly-converted hotel overlooking the city's Victoria Park, a location that has hosted pro-democracy protests for years, including an annual vigil marking Beijing's deadly Tiananmen crackdown.

Against the yen, the dollar was quoted at JPY107.55, broadly flat from JPY107.52 at the close on Tuesday.

The euro traded at USD1.1274 early Wednesday, down from USD1.1297 late Tuesday.

Sterling was quoted at USD1.2552 early Wednesday, softer than USD1.2586 at the London equities close on Tuesday.

Gold was priced at USD1,794.40 an ounce early Wednesday, higher than USD1,793.61 on Tuesday. Brent oil was trading at USD42.86 a barrel, lower than USD43.26.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.